Sign up to save your podcasts
Or
Share Illumina to divest Grail following FTC ruling; Medtronic has a Class I recall
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Illumina to divest Grail following FTC ruling; Medtronic has a Class I recall
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 20, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Merit Medical's founder and CEO announced plans to retire in 2025. Fast Five hosts Sean Whooley and Danielle Kirsh talk succession plans.
Butterfly Network is set to bring ultrasound-on-chip technology to surgical robotics with a new partnership. Hear what its latest partner does and how it will benefit patients.
Ablative Solutions hit its primary endpoint in renal denervation for hypertension in a trial. Whooley talks about the study's results and which data points were important.
Medtronic has a Class I recall for its surgical navigation software. Learn what devices are affected and what the issue is that affects the software.
Illumina is officially divesting Grail following a court decision that backed an FTC ruling. The Fast Five hosts talk about the final decision and how Illumina got to this point.
View all episodes
By MassDeviceWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, December 20, 2023.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Merit Medical's founder and CEO announced plans to retire in 2025. Fast Five hosts Sean Whooley and Danielle Kirsh talk succession plans.
Butterfly Network is set to bring ultrasound-on-chip technology to surgical robotics with a new partnership. Hear what its latest partner does and how it will benefit patients.
Ablative Solutions hit its primary endpoint in renal denervation for hypertension in a trial. Whooley talks about the study's results and which data points were important.
Medtronic has a Class I recall for its surgical navigation software. Learn what devices are affected and what the issue is that affects the software.
Illumina is officially divesting Grail following a court decision that backed an FTC ruling. The Fast Five hosts talk about the final decision and how Illumina got to this point.